Insomnia in Armodafinil - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Insomnia, when it was recovered, drug effectiveness, race, and more among people who take Armodafinil (armodafinil). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Armodafinil?

Armodafinil has active ingredients of armodafinil. It is often used in narcolepsy. eHealthMe is studying from 4,136 Armodafinil users. Check the latest studies of Armodafinil.

What is Insomnia?

Insomnia (sleeplessness) is found to be associated with 3,118 drugs and 5,168 conditions by eHealthMe. Check the latest studies of Insomnia.

On Jul, 04, 2026

21 people who have Insomnia while taking Armodafinil were studied.

Severity of Insomnia *:

least: 5 %
moderate: 55 %
severe: 25 %
most severe: 15 %

When people recovered from Insomnia *:

while on drug: 7.69 %
after off the drug: 23.08 %
not yet: 69.23 %

Effectiveness of Armodafinil *:

not at all: 5.26 %
somewhat: 26.32 %
moderate: 21.05 %
high: 26.32 %
very high: 21.05 %

Race of the people *:

African American, Non-Hispanic: 0.0 %
American Indian/Alaska Native: 0.0 %
Asian: 0.0 %
Hispanic: 5.56 %
Native Hawaiians/Pacific Islanders: 0.0 %
Two or more races: 0.0 %
White, Non-Hispanic: 94.44 %

Time on Armodafinil *:

Gender of people when taking Armodafinil *:

female: 76.19 %
male: 23.81 %

Age of people when taking Armodafinil *:

Conditions people have *:

Sleep Disorder: 4 people, 19.05%
Idiopathic Hypersomnia (severe excessive daytime sleepiness): 3 people, 14.29%
Stress And Anxiety: 3 people, 14.29%
Depression: 2 people, 9.52%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 9.52%
Pain: 2 people, 9.52%
High Blood Pressure: 2 people, 9.52%
Depressive Symptom: 1 person, 4.76%
High Blood Cholesterol: 1 person, 4.76%
Herpes Simplex (herpes simplex is a common viral infection): 1 person, 4.76%

Other drugs people take besides Armodafinil *:

Prednisone: 3 people, 14.29%
Lamictal Xr: 2 people, 9.52%
Bupropion Hydrochloride: 2 people, 9.52%
Multivitamin: 2 people, 9.52%
Clonazepam: 2 people, 9.52%
Diazepam: 2 people, 9.52%
Premarin: 2 people, 9.52%
Neurontin: 2 people, 9.52%
Trileptal: 2 people, 9.52%
Lorazepam: 2 people, 9.52%

Other side effects people have besides Insomnia *:

Fatigue (feeling of tiredness): 5 people, 23.81%
Agitation (state of anxiety or nervous excitement): 4 people, 19.05%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 14.29%
Dry Mouth: 3 people, 14.29%
Headache (pain in head): 3 people, 14.29%
Joint Pain: 3 people, 14.29%
Movement - Uncoordinated: 2 people, 9.52%
Confusion: 2 people, 9.52%
Diplopia (double vision): 2 people, 9.52%
Dizziness: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Armodafinil and have Insomnia?

Check whether Insomnia is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Insomnia in Armodafinil

How the study uses the data?

The study is based on armodafinil (the active ingredients of Armodafinil). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.